泰恩康：CKBA乳膏玫瑰痤疮适应症II/III期无缝适应性临床试验预计2025年12月正式入组病人

Group 1 - The company has provided updates on the progress of its CKBA ointment for treating vitiligo, indicating that any significant developments will be disclosed in accordance with regulatory requirements [2] - The Phase III clinical trial for the CKBA ointment targeting vitiligo is expected to officially start by the end of this year [2] - The seamless Phase II/III clinical trial for CKBA cream for treating rosacea is anticipated to begin patient enrollment by December 2025 [2]